tiprankstipranks
Trending News
More News >
Regen Biopharma, Inc. (RGBP)
:RGBP
US Market

Regen Biopharma (RGBP) Income Statement

Compare
120 Followers

Regen Biopharma Income Statement

Last quarter (Q1 2025), Regen Biopharma's total revenue was $59.06K, a decrease of 0.00% from the same quarter last year. In Q1, Regen Biopharma's net income was $-460.81K. See Regen Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 24Sep 23Sep 22Sep 21Sep 20
Total Revenue
$ 236.56K$ 236.56K$ 235.52K$ 171.19K$ 110.00K
Gross Profit
$ 159.34K$ 236.56K$ 185.52K$ 146.19K$ 110.00K
Operating Expenses
$ 577.53K$ 923.51K$ 575.12K$ 371.96K$ 319.32K
Depreciation and Amortization
$ 521.51K$ 1.90M$ 339.61K$ 200.77K$ 209.32K
EBITDA
$ -418.19K$ 1.22M$ 2.99M$ -6.40M$ 4.36M
Operating Income
$ -418.19K$ -686.95K$ -339.61K$ -200.77K$ -209.32K
Other Income/Expenses
$ -449.06K$ 1.84M$ 2.78M$ -6.56M$ 3.62M
Pretax Income
$ -867.25K$ 1.16M$ 2.44M$ -6.77M$ 3.41M
Net Income
$ -867.25K$ 1.02M$ 5.49M$ -7.13M$ 1.79M
Per Share Metrics
Basic EPS
$ -0.21$ 0.29$ 1.75$ -3.55$ 1.90
Diluted EPS
$ -0.21$ 0.29$ 1.75$ -3.55$ 1.90
Weighted Average Shares Outstanding
0.00 3.54M 3.14M 2.01M 939.90K
Weighted Average Shares Outstanding (Diluted)
0.00 3.54M 3.14M 2.01M 939.90K
Currency in USD

Regen Biopharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis